Please use this identifier to cite or link to this item:
|Title:||Antisense now makes sense: dual modulation of androgen-dependent transcription by CTBP1-AS||Authors:||Sung, Ying Ying.
|Keywords:||DRNTU::Science::Biological sciences||Issue Date:||2013||Source:||Sung, Y. Y., & Cheung, E. (2013). Antisense now makes sense: dual modulation of androgen-dependent transcription by CTBP1-AS. The EMBO Journal, 32(12), 1653-1654.||Series/Report no.:||The EMBO journal||Abstract:||Recent advances in genomic approaches for exploring the transcriptome have led to the identification of thousands of novel non-coding RNA (ncRNA) transcripts (Djebali et al, 2012). While some of these ncRNAs have been implicated in the development and progression of cancer and other human diseases, their underlying mechanisms of action remain largely unknown (Esteller, 2011). Takayama et al (2013) now report the identification of CTBP1-AS, a novel androgen-regulated long ncRNA that promotes prostate cancer growth through sense–antisense repression of the transcriptional co-regulator CTBP1, as well as through the global epigenetic regulation of tumour suppressor genes.||URI:||https://hdl.handle.net/10356/98266
|DOI:||10.1038/emboj.2013.112||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SBS Journal Articles|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.